Candid Therapeutics
Candid Therapeutics
Revolutionary RNA Carriers: Exomeres Unveiled!
BIOT
Discover how MSU researchers developed a scalable method for purifying nuclease-proof exomeres, advancing RNA-based therapeutics! ✨🔬📦🌱📈
Candid and WuXi: $925 Million Cancer Breakthrough!
BIOT
Candid Therapeutics partners with WuXi Biologics to advance trispecific T-cell engagers, aiming for $925 million in potential milestones! 💰🌍📰
